Cataract surgeons adopting interventional glaucoma treatments

Whether surgeons adopt cataract surgery-paired MIGS implants or a broader range of interventional therapies, our practices will change because we are so well positioned to meet patients' urgent need for glaucoma therapy beyond eye drops. Today, I use CyPass (Alcon Laboratories) or iStent (Glaukos) during cataract surgery, as well as standalone procedures such as the Kahook Dual Blade (New World Medical), Visco 360 (Sight Sciences) and XEN Gel Stent (Allergan). Insurance carriers vary widely in what they are willing to cover, despite the long-term benefits of reducing reliance on patients' compliance with drops to preserve vision and avoid major surgery.